Oramed Pharmaceuticals Inc.
ORMP· Nasdaq
ORMPOramed Pharmaceuticals Inc.
Filed Nov 29, 2011 · 10-K · 90 days after period end · 0001178913-11-003216
derived · Computed from the longer spans the company filed.
no prior Q4 2010 on file
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Aug 31, 2011 · filed Nov 29, 2011 · 90 d after period end
Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR
